对于患有轻度认知障碍和痴呆症的成年人来说,联合炼和认知干预:系统性审查和网络元分析
Dandan Xue1, Polly W C Li1, Doris S F Yu1
1School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
International journal of nursing studies
|September 28, 2023
概括
运动和认知干预措施的结合对痴呆症患者有好处,单独的运动和相匹配的认知干预措施的表现优于运动. 多模式运动与认知训练提供了最好的全球认知改进.
科学领域:
- 老年学和认知神经科学
- 临床神经学和康复 临床神经学和康复
背景情况:
- 运动和认知干预对患有痴呆症的成年人有好处.
- 综合干预和最佳设计的协同效应尚不清楚.
研究的目的:
- 在轻度认知障碍和痴呆症中,将联合炼和认知干预与单个方法和对照进行比较.
- 确定最佳的干预设计和影响因素.
主要方法:
- 对29项随机对照试验 (2910名参与者) 的系统综述和元分析.
- 偏见的可克兰风险是质量评估的工具.
- 双向和网络元分析以评估影响并确定最佳组件.
主要成果:
- 综合干预措施超过了特定认知功能 (反应抑制,工作记忆,延迟回忆) 的运动.
- 与对照组相比,联合干预改善了全球认知和其他认知领域.
- 多模式运动与认知训练显示出最大的全球认知改进.
结论:
- 综合干预比运动更有优势,效果与轻度认知障碍和痴呆症的认知干预相似.
- 建议进行进一步的大规模试验,将联合干预直接与认知干预进行比较.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.8K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
相关概念视频
Cognitive Development During Adulthood
142
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
142
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
147
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
147
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
